Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,445	1,128	1,833	1,733	1,184	1,048
Market Cap Growth	-10.28%	-38.43%	5.75%	46.42%	12.95%	339.76%
Enterprise Value	1,336	723	1,461	1,384	969	893
Last Close Price	16.62	13.22	21.61	25.45	21.89	22.24
PE Ratio	-	-	-	-	47.49	-
PS Ratio	12.92	47.65	-	-	8.47	690.79
PB Ratio	12.51	3.92	3.31	3.71	2.90	4.16
P/TBV Ratio	12.51	3.92	3.31	3.71	2.90	4.16
P/FCF Ratio	-	-	-	-	40.81	-
P/OCF Ratio	-	-	-	-	40.63	-
EV/Sales Ratio	12.00	30.53	-	-	6.94	588.50
EV/EBITDA Ratio	-	-	-	-	36.90	-
EV/EBIT Ratio	-	-	-	-	36.96	-
EV/FCF Ratio	-	-	-	-	33.42	-
Debt / Equity Ratio	2.99	1.20	0.00	0.00	0.05	0.08
Debt / EBITDA Ratio	-	-	-	-	0.79	-
Debt / FCF Ratio	-	-	-	-	0.72	-
Asset Turnover	0.23	0.04	-	-	0.37	0.01
Quick Ratio	4.36	5.76	9.96	16.81	21.62	15.79
Current Ratio	4.64	5.82	10.00	16.85	21.68	15.84
Return on Equity (ROE)	-129.32%	-75.69%	-40.98%	-34.10%	7.55%	-51.56%
Return on Assets (ROA)	-39.24%	-31.74%	-25.89%	-20.03%	4.37%	-24.52%
Return on Capital (ROIC)	-46.32%	-35.69%	-28.06%	-21.13%	4.67%	-29.25%
Return on Capital Employed (ROCE)	-	-	-	-	6.10%	-
Earnings Yield	-21.57%	-28.25%	-11.42%	-8.62%	2.11%	-6.98%
FCF Yield	-21.53%	-24.36%	-8.76%	-7.71%	2.45%	-6.80%
Buyback Yield / Dilution	-5.39%	-21.67%	-15.82%	-13.31%	-29.81%	-35.48%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q